Rapid extracellular degradation of synthetic class I peptides by human dendritic cells

Journal of Immunology

Volumn 161, Issue 8, 1998, Pages 4023-4032

  Amoscato, Andrew A ^a,b   Prenovitz, Damon A ^a,b   Lotze, Michael T ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; UBIQUITIN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; DENDRITIC CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEQUENCE ANALYSIS;

CELL MEMBRANE; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MEMBRANE PROTEINS; PEPTIDES; SEQUENCE ANALYSIS; SUBSTRATE SPECIFICITY;

EID: 0032532350     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Romanin, N., E. Kampgen, F. Koch, C. Heufler, and G. Schuler. 1990. Dendritic cell production of cytokines and responses to cytokines. Int. Rev. Immunol. 6:151.
2. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by GM-CSF plus IL-4 and down-regulated by TNFα. J. Exp. Med. 179:1109.
3. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
4. Roman, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Konwlinka, G. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in blood. J. Exp. Med. 180:83.
5. Becker, Y. 1993. Dendritic cell activity against primary tumors: and overview. In Vivo 7:187.
6. Zeid, N. A., and H. K. Muller. 1993. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 25: 338.
7. Furihata, M., Y. Ohtsuki, E. Ido, J. Iwata, H. Sonobe, K. Araki, S. Ogoshi, and K. Ohmori. 1992. HLA-DR antigen and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma: their distribution in relation to prognosis. Virchows Arch. B61:409.
8. Tsujitani, S., Y. Kakeji, A. Watanabe, S. Kohnoe, Y. Maehara, and K. Sugimachi. 1990. Infiltration of dendritic cells in relationship to tumor invasion and lymph node metastasis in human gastric cancer. Cancer 66:2012.
9. Giannini, A., S. Bianchi, L. Messerini, O. Gallo, E. Gallina, G. Asprella-Libonati, P. Olmi, and G. Zampi. 1991. Prognostic significance of accessory cells and lymphocytesin nasopharyngeal carcinoma. Pathol. Res. Pract. 187:498.
10. Murphy, G., F. Radu, M. Kaminer, and D. Berd. 1993. Autologous melanoma vaccine induces inflammatory responses in melanoma metastases: relevance to immunologic regression and immunotherapy. J. Invest. Dermatol. 100:335S.
11. Knight, S. C., R. Hunt, C. Dore, and P. B. Medawar. 1985. Influence of dendritic cells on tumor growth. Proc. Natl. Acad. Sci. USA 82:4495.
12. Flamand, V., T. Sornasse, K. Thielemans, C. Demanet, M. Bakkus, H. Bazin, P. Thielemans, O. Leo, J. Urbain, and M. Moser. 1994. Murine dendritic cells pulsed with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605.
13. Austen, J. M. 1993. The dendritic cell system and anti-tumor immunity. In Vivo 7:193.
14. Inaba, K. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with GM-CSF. J. Exp. Med. 176:1693.
15. Mayordomo, J. I., T. Zorina, W. J. Storkus, L. Zivogel, C. Celluzzi, L. D. Falo, C. J. Melief, S. T. Ildstad, W. M. Kast, A. DeLeo, et al. 1995. Bone marrow derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic anti-tumor immunity. Nat. Med. 1:1297.
16. Celluzzi, C. M., J. I. Mayordomo, W. J. Storkus, M. T. Lotze, and L. D. Falo. 1996. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective immunity. J. Exp. Med. 283:88.
17. Zitvogel, L., J. I. Mayordomo, T. Tjandrawan, A. B. DeLeo, M. R. Clarke, and M. T. Lotze. 1996. Therapy for murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cell B7 costimulation and T helper cell-associated cytokines. J. Exp. Med. 183:87.
18. Kiyokanan, K., K. Ishimoto, H. Fujita, J. Fujimoto, and J.-I. Hata. 1990. Characterization of the common acute lymphoblastic leukemia antigen (CD10) as an activation molecule on human B cells. Clin. Exp. Immunol. 79:322.
19. - subpopulations. Eur. J. Immunol. 20:459.
20. Look, A. T., R. A. Ashmun, L. H. Shapiro, and S. C. Peiper. 1989. Human myeloid plasma membrane glycoprotein CD13 is identical to aminopeptidase N. J. Clin. Invest. 83:1299.
21. Ashmun, R. A., and A. T. Look. 1990. Metalloprotease activity of CD13 aminopeptidase N on the surface of myeloid cells. Blood 75:462.
22. Naquet, P., I. Vivier, J.-P. Gorvel, P. Brekemans, M. Barad, A.-M. Bernard, and M. Pierres. 1989. Activation of mouse T-lymphocytes by a monoclonal antibody to a developmentally regulated surface aminopeptidase (THAM). Immunol. Rev. 11:77.
23. Wu, Q., J. M. Lahti, P. D. Burrows, and M. D. Cooper. 1990. Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metalloprotease family. Proc. Natl. Acad. Sci. USA 87:993.
24. Wu, A., L. Li, M. D. Cooper, M. Pierres, and J. P. Gorvel. 1991. Aminopeptidase A activity of the murine B-lymphocyte differentiation antigen BP-1/6C3. Proc. Natl. Acad. Sci. USA 88:676.
25. Halfer, D. A., M. Chofflon, D. Benjamin, N. H. Dang, and J. B. Breitmeyer. 1989. Mechanisms of immune memory T cell activation and CD3 phosphorylation correlates with Ta1 (Cdw26) expression. J. Immunol. 142:2590.
26. Dang, N. H., D. A. Halfer, S. F. Schlossman, and J. B. Brietmeyer. 1990. FcR-mediated crosslinking of Ta1 (Cdw26) induces human T lymphocyte activation. Cell. Immunol. 125:42.
27. Stamenkovic, I., H. C. Asheim, A. Deggerdac, H. K. Blomhoff, E. B. Smeland, and S. Funderud. 1990. The B-cell antigen CD75 is a cell surface sialyltransferase. J. Exp. Med. 172:641.
28. Dang, N. H., Y. Torimoto, K. Deusch, S. F. Schlossman, and C. Monmoto. 1990. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J. Immunol. 144:4092.
29. Hegen, M., G. Nieddobitek, C. E. Klein, H. Stein, and B. Fleischer. 1990. The T-cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J. Immunol. 144:2908.
30. O'Connell, P. J., V. Gerkis, and A. J. F. D'Apice. 1989. CD13: a signal transduction molecule on myeloid cells? Transplant. Proc. 21:3826.
31. Thompson, L. F., J. M. Ruedi, A. Glass, M. G. Low, and A. H. Lucas. 1989. Antibodies to 5′-nucleotidase (CD73), a glycosyl-phophatidylinositol-anchored protein, cause human peripheral blood T cells to proliferate. J. Immunol. 140: 1815.
32. Dang, N. H., Y. Torimoto, K. Sugita, J. F. Daley, P. Schow, C. Prado, S. F. Schlossman, and C. Morimoto. 1990. Cell surface modulation of CD26 by 1F7 monoclonal antibody: analysis of surface expression and human T-cell activation. J. Immunol. 145:3963.
33. Piazza, G. A., H. M. Callanan, J. Mowery, and D. Hixson, 1989. Evidence for a type of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Biochem. J. 262:327.
34. Dang, N. H., Y. Torimoto, S. F. Schlossman, and C. Morimoto. 1990. Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VCA integrin family. J. Exp. Med. 172:649.
35. Aurivillius, M., O. C. Hansen, M. B. S. Lazrek, E. Bock, and B. Orbink. 1990. The cell adhesion molecule cell-CAM 105 is an ecto-ATPase and a member of the immunoglobulin family. FEBS Lett. 264:267.
36. Daikiri, K., S. Nakamura, S. Ikegami, M. Nakamura, T. Fujimori, N. Tamaoki, and N. Tada. 1989. Mouse Ly-31. 1 is an alloantigenic determinant D alkaline phosphatase predominantly expressed in the kidney and bone. Immunogenetics 29:235.
37. Marquez, C., A. De La Hera, E. Leonardo, L. Pezzi, A. Stasser, and A. C. Martinez. 1990. Identity of PB76 differentiation antigen and lymphocyte alkaline phosphatase. Immunogenetics 20:947.
38. Tiruppathi, C., Y. Miyamoto, V. Ganapathy, T. A. Roesel, G. M. Whitford, and F. H. Leibach. 1990. Hydrolysis and transport of proline-containing peptides in renal brush-border membrane vesicles from dipeptidyl peptidase IV-positive and negative rat strains. J. Biol. Chem. 265:1476.
39. Mouritsen, S., M. Meldal, O. Werdelin, A. Stryhn Hansen, and S. Buus. 1992. MHC molecules protect T cell epitopes against proteolytic destruction. J. Immunol. 149:1987.
40. Falk, K., O. Roetzschke, S. Stefanovic, G. Jung, and H. G. Rammensee. 1994. Pool sequencing of natural HLA-DR, -DQ and -DP ligands reveals detailed peptide motifs, constraints of processing and general rules. Immunogenetics 39:230.
41. Larsen, S., L. Ostergaard, S. Buus, and A. Stryhn. 1996. T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatability complex class II-bound peptides. J. Exp. Med. 184:183.
42. Amoscato, A. A., J. W. Alexander and G. F. Babcock. 1989. Surface aminopeptidase activity of human lymphocytes. I. Biochemcial and biologic properties. J. Immunol. 142:1245.
43. Amoscato, A. A., R. R. Spiess, A. M. Brumfield, R. B. Herberman, and W. H. Chambers. 1993. Surface aminopeptidase activity of rat NK cells. Biochim. Biophys. Acta 1221:221.
44. Berg, H. C. 1969. Sulfanilic acid diazonium salt: a label for the outside of the human erythrocyte membrane. Biochim. Biophys. Acta 183:65.
45. Sallusto, F., M. Cella, C. Danieli, and A. Lansavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatability complex class I compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389.
46. Steinman, R. M., and J. Swanson. 1995. The endocytic activity of dendritic cells. J. Exp. Med. 182:283.
47. Menrad, A., D. Speicher, J. Wacker, and M. Herlyn. 1993. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res. 53:1450.
48. Saiki, I., H. Fujii, J. Yoneda, F. Abe, M. Nakajima, T. Tsuruo, and I. Azuma. 1993. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer 54:137.
49. Barrett, A. J. 1977. Cathepsin D and other carboxyl proteinases. In Proteinases in Mammalian Cells and Tissues. A. J. Barrett, ed. North-Holland Publishing Co., Amsterdam, pp. 209-248.
50. Kanayama, N., Y. Kajiwara, J. Goto, E. El Maradny, K. Maehara, K. Andou, and T. Tereo. 1995. Inactivation of interleukin-8 by aminopeptidase N (CD13). J. Leukocyte Biol. 57:129.
51. Delmas, B., J. Gelfi, R. L'Haridou, L. K. Vogel, H. Sjostrom, O. Noren, and H. Lunde. 1992. Aminopeptidase N is a major receptor for the enteropathogenic corona virus TGEV. Nature 357:417.
52. Yeager, C. L., R. A. Ashmun, R. K. Williams, C. B. Cardellichio, L. H. Shapiro, A. T. Look, and K. V. Holmes. 1992. Human aminopeptidase N is a major receptor for human corona virus 229E. Nature 357:420.
53. Giugni, T. D., C. Soderberg, D. J. Hamm, R. M. Bautista, K. O. Hedlund, E. Moller, and J. A. Zaia. 1996. Neutralization of human cytomegalovirus by human CD13-specific antibodies. J. Infect. Dis. 173:106.